Literature DB >> 2663992

Analysis of human IL-6 mutants expressed in Escherichia coli. Biologic activities are not affected by deletion of amino acids 1-28.

J P Brakenhoff1, M Hart, L A Aarden.   

Abstract

We have constructed and analyzed amino terminally deleted analogs of IL-6. Progressively shortened variants of mature IL-6 were constructed at the cDNA level and expressed in Escherichia coli. Mutant proteins were recovered from refractile bodies by solubilizing in 6 M guanidine-HCl. The mutant protein concentration in these preparations was estimated by Western blotting by using an IL-6-specific mAb and the biologic activity was measured in the B9 (hybridoma growth factor) assay. The first 28 amino acids of mature IL-6 could be removed without significantly affecting biologic activity. A further removal of amino acids 29 and 30 resulted in an approximately 50-fold decrease, whereas removal of amino acids 31 to 34 virtually abolished the activity. The mutants showed the same reaction pattern in three other IL-6 assays: induction of murine thymocyte proliferation, induction of fibrinogen synthesis by a human hepatoma cell line (HepG2), and the induction of IgM synthesis by an EBV-transformed B cell line. This suggests that a single functional domain might be responsible for all four activities of IL-6.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663992

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization.

Authors:  A E Proudfoot; S C Brown; P Graber; F Talabot; C Y Arod; M C Peitsch; M Banks; M McKinnon; R Solari; T N Wells
Journal:  J Protein Chem       Date:  1996-07

Review 2.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

3.  Structure-function studies of human ciliary neurotrophic factor.

Authors:  A Negro; V Corsa; G Corona; C Grandi; S D Skaper; L Callegaro
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

4.  Human ciliary neurotrophic factor: a structure-function analysis.

Authors:  A Krüttgen; J Grötzinger; G Kurapkat; J Weis; R Simon; M Thier; M Schröder; P Heinrich; A Wollmer; M Comeau
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

5.  Role of the C-terminus in the activity, conformation, and stability of interleukin-6.

Authors:  L D Ward; A Hammacher; J G Zhang; J Weinstock; K Yasukawa; C J Morton; R S Norton; R J Simpson
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

6.  Effect of pH and denaturants on the folding and stability of murine interleukin-6.

Authors:  L D Ward; J G Zhang; G Checkley; B Preston; R J Simpson
Journal:  Protein Sci       Date:  1993-08       Impact factor: 6.725

7.  Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.

Authors:  K Kaushansky; S G Shoemaker; V C Broudy; N L Lin; J V Matous; E M Alderman; J D Aghajanian; P J Szklut; R E VanDyke; M K Pearce
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 8.  Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense.

Authors:  L Graeve; M Baumann; P C Heinrich
Journal:  Clin Investig       Date:  1993-08

9.  Recombinant human IL-6 expressed in E. coli undergoes selective N-terminal degradation: evidence that the protein consists of a stable core and a nonessential flexible N-terminal.

Authors:  A E Proudfoot; S C Brown; A R Bernard; J Y Bonnefoy; E H Kawashima
Journal:  J Protein Chem       Date:  1993-08

10.  Molecular cloning and sequencing of interleukin 6 cDNA fragments from the harbor seal (Phoca vitulina), killer whale (Orcinus orca), and Southern sea otter (Enhydra lutris nereis).

Authors:  D P King; M D Schrenzel; M L McKnight; T H Reidarson; K D Hanni; J L Stott; D A Ferrick
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.